Approved for use through 11/30/2020. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`SubstItute for form 1449/PTO
`
`Complete if Known
`
`INFORMATION DISCLOSURE ——g:;3,2,‘,11,f,,,,.Timom A
`
`STATEMENT BY APPLICANT E1637 ’
`y
`'
`(Use as many sheets as necessary)
`—STRZELECKA, TERESA E
`Attorney Docket Number
`A 7697-709201
`
`—15952203
`W D t
`
`Examiner
`'
`'
`*
`
`Document Number
`
`Number-Kind Code2 (”km")
`
`U. S. PATENT DOCUMENTS
`Publication Date
`Name of Patentee or
`MM-DD-YYYY
`Applicant of Cited Document
`
`9
`Pa es, Columns, Lines, Where
`Relevant Passages or Relevant
`Figures Appear
`
`FOREIGN PATENT DOCUMENTS
`
`Examiner
`lnitials*
`
`.
`
`Foreign Patent Document
`
`
`
`Publication
`Date
`MM-DD-YYYY
`
`Name of Patentee or
`Applicant of Cited Document
`
`Pages, Columns, Lines,
`Where Relevant Passages
`Or Relevant Figures Appear
`
`
`
`
`
`Country Codea’NumberA’Kind Codes (if known)
`
`WO-2013138536-A1
`
`WO-2015173402-A1
`
`SWIFT
`09-19-2013 BIOSCIENCES
`
`RUPRECHT
`KARLS
`11-19-2015 UNIVERSITAT
`HEIDELBERG
`
`[DE], et al.
`
`WO-2018057820-A1
`
`03-29-2018
`
`[FEED'C'NE 'NC
`
`WO-2018119452-A2
`
`GUARDANT
`06-28-2018 HEALTH INC [US]
`
`*EXAMINER: lnitial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not
`considered lnclude copy of this form with next communication to applicant. Applicant’s unique citation designation number (optional). See Kinds Codes of USPTO Patent
`Documents at www. uspto.gov or MPEP 901. 04. Enter Office that issued the document, by the two- letter code (WIPO Standard ST.3). For Japanese patent documents, the
`6
`indication of the year of the reign of the Emperor must precede the serial number of the patent document. Kind of document by the appropriate symbols as indicated on the
`document under WlPO Standard ST.16 if possible. Applicant is to place a check mark here if English language Translation is attached. This collection of information is required by
`37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is
`governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to complete, including gathering, preparing, and submitting the completed application
`form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to complete this form and/or suggestions for reducing this
`burden, should be sent to the Chief Information Officer, US. Patent and Trademark Office, PO. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED
`FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.0. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800—PTO-9199 (1 -800-786-91 99} and select option 2.
`
`

`

`Approved for use through 11/30/2020. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`Substitute for form 1449/PTO
`
`Complete if Known
`
`INFORMATION DISCLOSURE ——g:,13j,‘,11,f,,,,.Timom A
`
`STATEMENT BY APPLICANT E1637 ’
`y
`'
`(Use as many sheets as necessary)
`—STRZELECKA, TERESA E
`Attorney Docket Number
`A 7697-709201
`
`—15952203
`W D t
`
`-- PCT/U82018/027393 International Search Report and Written Opinion dated July 16, 2018. a
`
`NON-PATENT LITERATURE DOCUMENTS
`
`Examiner
`Initials*
`
`.
`
`Include name ofthe author(in CAPITAL LETTERS),titIe of the article(when appropriate), title of
`the item (book,magazine,journal,serial,symposium,cata|og,etc.),date,page(s),vo|ume-issue
`number(s),publisher, city and/or country where published.
`
`001
`
`DEY, S. et al., Integrated genome and transcriptome sequencing from the same cell, Nat.
`Biotechnol. 2015, 33(3), p285-289.
`
`Examiner
`Signature
`
`Date
`Considered
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not considered. Include
`copy of this form with next communication to applicant. 1 Applicant’s unique citation designation number (optional). 2 Applicant is to place a check mark here if English language
`Translation is attached. This collection of information is required by 37 CFR 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by the
`USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to complete, including gathering,
`preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, US. Patent and Trademark Office, PO. Box 1450, Alexandria, VA
`22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.0. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800—PTO-9199 (1 -800-786-91 99} and select option 2.
`
`

`

`Approved for use through 11/30/2020. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`Substitute for form 1449/PTO
`
`Complete if Known
`
`INFORMATION DISCLOSURE ——gfigfijv‘p,fmp.Timom A
`
`STATEMENT BY APPLICANT E1637 ’
`y
`'
`(Use as many sheets as necessary)
`—STRZELECKA, TERESA E
`Attorney Docket Number
`A 7697-709201
`
`—15952203
`W D t
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s):
`
`CERTIFICATION STATEMENT
`
`I:I
`
`That each item of information contained in the information disclosure statement was first cited in any
`communication from a foreign patent office in a counterpart foreign application not more than three months priorto
`the filing of the information disclosure statement. See 37 CFR 1.97(e)(1).
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`
`to the knowledge of the person signing the
`foreign patent office in a counterpart foreign application, and,
`certification after making reasonable inquiry, no item of information contained in the information disclosure
`statement was known to any individual designated in 37 CFR 1.56(c) more than three months prior to the filing of
`the information disclosure statement. See 37 CFR 1.97(e)(2).
`
`
`
`I:I
`
`See attached certification statement.
`
`I:I
`
`Fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`XI A certification statement is not submitted herewith.
`
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for
`the form ofthe signature.
`
`SIGNATURE
`
`Name/Print
`
`Registration Number
`
`73674
`
`/Derrick Rowe/
`
`Date (YYYY-MM-DD)
`
`2019-10-28
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit
`by the public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122
`and 37 CFR1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the
`completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the
`amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief
`Information Officer, US. Patent and Trademark Office, US. Department of Commerce, PO. Box 1450, Alexandria, VA
`22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for
`
`Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requiresthat you be given certain information in connection with yoursubmission of
`the attached form related to a patent application or patent. Accordingly, pursuantto the requirements of the Act, please be
`advised that: (1) the general authority forthe collection ofthis information is 35 U.S.C. 2(b)(2); (2) furnishing ofthe information
`solicited is voluntary; and (3) the principal purpose for which the information is used bythe US. Patent and Trademark Office
`is to process and/or examine your submission related to a patent application or patent. If you do not furnish the requested
`information, the US. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration ofthe patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request
`involving an individual, to whom the record pertains, when the individual has requested assistance from the Member
`with respect to the subject matter of the record.
`A record in this system of records may be disclosed, as a routine use, to a contractor ofthe Agency having need
`forthe information in orderto perform a contract. Recipients of information shall be required to comply with the
`requirements ofthe Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`A record related to an International Application filed underthe Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization,
`pursuant to the Patent Cooperation Treaty.
`A record in this system of records may be disclosed, as a routine use, to anotherfederal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`. A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or
`his/her designee, during an inspection of records conducted by GSA as part ofthat agency's responsibility to
`recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904
`and 2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records
`for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not be used to
`make determinations about individuals.
`
`1. The information on this form will be treated confidentially to the extent allowed underthe Freedom of Information Act
`(5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records may be disclosed to the
`Department ofJustice to determine whether disclosure ofthese records is required by the Freedom of Information
`Act.
`
`. A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance ofa patent pursuantto 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of37 CFR 1.14, as a routine use, to the public ifthe record was filed
`in an application which became abandoned or in which the proceedings were terminated and which application is
`referenced by eithera published application, an application opento public inspection or an issued patent.
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, ifthe USPTO becomes aware of a violation or potential violation of law or regulation.
`
`